Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study

Detalles Bibliográficos
Autores principales: Nakano, Hidehiko, Matsubara, Tsunehiro, Yamakawa, Kazuma, Nakamura, Kensuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189509/
https://www.ncbi.nlm.nih.gov/pubmed/32345334
http://dx.doi.org/10.1186/s13054-020-02842-5
_version_ 1783527511372595200
author Nakano, Hidehiko
Matsubara, Tsunehiro
Yamakawa, Kazuma
Nakamura, Kensuke
author_facet Nakano, Hidehiko
Matsubara, Tsunehiro
Yamakawa, Kazuma
Nakamura, Kensuke
author_sort Nakano, Hidehiko
collection PubMed
description
format Online
Article
Text
id pubmed-7189509
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71895092020-05-04 Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study Nakano, Hidehiko Matsubara, Tsunehiro Yamakawa, Kazuma Nakamura, Kensuke Crit Care Research Letter BioMed Central 2020-04-28 /pmc/articles/PMC7189509/ /pubmed/32345334 http://dx.doi.org/10.1186/s13054-020-02842-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
Nakano, Hidehiko
Matsubara, Tsunehiro
Yamakawa, Kazuma
Nakamura, Kensuke
Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title_full Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title_fullStr Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title_full_unstemmed Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title_short Urine TITIN N-fragment as a novel biomarker for critical illness myopathy: a pilot study
title_sort urine titin n-fragment as a novel biomarker for critical illness myopathy: a pilot study
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189509/
https://www.ncbi.nlm.nih.gov/pubmed/32345334
http://dx.doi.org/10.1186/s13054-020-02842-5
work_keys_str_mv AT nakanohidehiko urinetitinnfragmentasanovelbiomarkerforcriticalillnessmyopathyapilotstudy
AT matsubaratsunehiro urinetitinnfragmentasanovelbiomarkerforcriticalillnessmyopathyapilotstudy
AT yamakawakazuma urinetitinnfragmentasanovelbiomarkerforcriticalillnessmyopathyapilotstudy
AT nakamurakensuke urinetitinnfragmentasanovelbiomarkerforcriticalillnessmyopathyapilotstudy

Ejemplares similares